Formycon AG (XTER:FYB) Other Long-Term Liabilities : €310.49 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Other Long-Term Liabilities?

Formycon AG's other long-term liabilities for the quarter that ended in Dec. 2023 was €310.49 Mil.

Formycon AG's quarterly other long-term liabilities declined from Dec. 2022 (€438.86 Mil) to Jun. 2023 (€395.72 Mil) and declined from Jun. 2023 (€395.72 Mil) to Dec. 2023 (€310.49 Mil).

Formycon AG's annual other long-term liabilities increased from Dec. 2021 (€3.44 Mil) to Dec. 2022 (€438.86 Mil) but then declined from Dec. 2022 (€438.86 Mil) to Dec. 2023 (€310.49 Mil).

Formycon AG Other Long-Term Liabilities Historical Data

The historical data trend for Formycon AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Other Long-Term Liabilities Chart

Formycon AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Formycon AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Formycon AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Formycon AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Formycon AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Formycon AG (XTER:FYB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

FYB:Germany FYB:Germany FYB:Germany

Address

Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.formycon.com

Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.

Executives

Dr. Stefan Glombitza	Board of Directors
Dr. Carsten Brockmeyer	Board of Directors
Dr. Nicolas Combé	Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines